ATE322280T1 - Verwendung von daptomycin - Google Patents

Verwendung von daptomycin

Info

Publication number: ATE322280T1
Authority: AT; Austria
Prior art keywords: daptomycin; administering; muscle toxicity; skeletal muscle; effective amount
Prior art date: 1998-09-25

Application number

AT99949913T

Other languages

English (en)

Inventor

Frederick B Oleson Jr

Francis P Tally

Original Assignee

Cubist Pharm Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-09-25

Filing date

1999-09-24

Publication date

2006-04-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26798675&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE322280(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1999-09-24 Application filed by Cubist Pharm Inc filed Critical Cubist Pharm Inc

2006-04-15 Application granted granted Critical

2006-04-15 Publication of ATE322280T1 publication Critical patent/ATE322280T1/de

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/10—Peptides having 12 to 20 amino acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Immunology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Gastroenterology & Hepatology (AREA)
Organic Chemistry (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Saccharide Compounds (AREA)

AT99949913T 1998-09-25 1999-09-24 Verwendung von daptomycin ATE322280T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US10182898P	1998-09-25	1998-09-25
US12575099P	1999-03-24	1999-03-24

Publications (1)

Publication Number	Publication Date
ATE322280T1 true ATE322280T1 (de)	2006-04-15

Family

ID=26798675

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT99949913T ATE322280T1 (de)	1998-09-25	1999-09-24	Verwendung von daptomycin

Country Status (26)

Country	Link
US (2)	US6468967B1 (de)
EP (2)	EP1674107B8 (de)
JP (4)	JP4184607B2 (de)
KR (2)	KR20010075327A (de)
CN (2)	CN1530136A (de)
AT (1)	ATE322280T1 (de)
AU (1)	AU764348B2 (de)
BR (1)	BR9914051A (de)
CA (1)	CA2344318C (de)
CY (3)	CY1105556T1 (de)
DE (3)	DE122006000049I1 (de)
DK (2)	DK1115417T3 (de)
ES (2)	ES2259845T3 (de)
HK (1)	HK1040363B (de)
HU (1)	HU230656B1 (de)
IS (2)	IS5890A (de)
LU (1)	LU91254I2 (de)
NL (1)	NL300232I2 (de)
NO (1)	NO20011454L (de)
NZ (1)	NZ510690A (de)
PL (2)	PL203689B1 (de)
PT (2)	PT1674107T (de)
RU (1)	RU2363489C9 (de)
SI (2)	SI1674107T1 (de)
TR (1)	TR200100841T2 (de)
WO (1)	WO2000018419A2 (de)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
PT1674107T (pt)	1998-09-25	2016-12-07	Cubist Pharmaceuticals Llc	Utilização de daptomicina
AU784755B2 (en)	1999-12-15	2006-06-08	Merck Sharp & Dohme Corp.	Daptomycin Analogs as antibacterial agents
US6696412B1 (en)	2000-01-20	2004-02-24	Cubist Pharmaceuticals, Inc.	High purity lipopeptides, Lipopeptide micelles and processes for preparing same
KR20030081353A (ko)	2000-12-18	2003-10-17	큐비스트 파마슈티컬즈 인코포레이티드	정제된 리포펩티드의 제조 방법
US20060014674A1 (en)	2000-12-18	2006-01-19	Dennis Keith	Methods for preparing purified lipopeptides
WO2002059145A1 (en) *	2000-12-18	2002-08-01	Cubist Pharmaceuticals, Inc.	Methods for preparing purified lipopeptides
EP1932853A1 (de)	2001-08-06	2008-06-18	Cubist Pharmaceutical Inc.	Neue Depsipeptide und Herstellungsverfahren dafür
US20040147441A1 (en) *	2002-08-23	2004-07-29	Leach Timothy S.	Methods and reagents for preventing bacteremias
US20050277581A1 (en) *	2002-11-18	2005-12-15	Vicuron Pharmaceuticals Inc.	Dalbavancin compositions for treatment of bacterial infections
US20060074014A1 (en) *	2002-11-18	2006-04-06	Vicuron Pharmaceuticals Inc.	Dalbavancin compositions for treatment of bacterial infections
US20050220862A1 (en) *	2004-03-31	2005-10-06	Bernstein Joel E	Compositions with reduced hepatotoxicity
US20060004185A1 (en) *	2004-07-01	2006-01-05	Leese Richard A	Peptide antibiotics and peptide intermediates for their prepartion
US20060014677A1 (en) *	2004-07-19	2006-01-19	Isotechnika International Inc.	Method for maximizing efficacy and predicting and minimizing toxicity of calcineurin inhibitor compounds
US20080051326A1 (en) *	2004-11-12	2008-02-28	Alexander Dylan C	Antiinfective Lipopeptides
US8524734B2 (en)	2005-05-18	2013-09-03	Mpex Pharmaceuticals, Inc.	Aerosolized fluoroquinolones and uses thereof
US7838532B2 (en) *	2005-05-18	2010-11-23	Mpex Pharmaceuticals, Inc.	Aerosolized fluoroquinolones and uses thereof
US20070238630A1 (en) *	2006-03-29	2007-10-11	Phillips Douglas H	Subcutaneous skin cleanser
EP2018864A1 (de)	2007-07-23	2009-01-28	Biomet Deutschland GmbH	Pharmazeutische Zusammensetzung, Substrat mit einer pharmazeutischen Zusammensetzung und Verwendung einer pharmazeutischen Zusammensetzung
KR20100137439A (ko) *	2008-03-04	2010-12-30	엘란 파마 인터내셔널 리미티드	항감염제의 안정성 액체 포뮬레이션 및 항감염제의 조정된 용량투여 요법
CA2731113A1 (en)	2008-07-17	2010-03-18	Acorda Therapeutics, Inc.	Therapeutic dosing of a neuregulin or a subsequence thereof for treatment or prophylaxis of heart failure
DE102008046610A1 (de) *	2008-09-09	2010-03-11	Biomet Deutschland Gmbh	Verwendung einer pharmazeutischen Zusammensetzung zur lokalen Infektionstherapie sowie Medizinprodukt
MX345158B (es)	2008-10-07	2017-01-18	Raptor Pharmaceuticals Inc	Formulaciones de fluoroquinolona en aerosol para farmacocinetica mejorada.
SI2346509T1 (sl)	2008-10-07	2020-08-31	Horizon Orphan Llc	Inhalacija levofloksacina za zmanjšanje vnetja pljuč
WO2010048630A1 (en) *	2008-10-24	2010-04-29	Los Angeles Biomedical Reserch Institute At Harbor-Ucla Medical Center	Anti-infective hydroxy-phenyl-benzoates and methods of use
EP2379580B1 (de)	2008-12-22	2013-10-23	Cubist Pharmaceuticals, Inc.	Neue antibakterielle mittel zur behandlung von gram-positiven infektionen
WO2010075416A1 (en)	2008-12-23	2010-07-01	Biosource Pharm, Inc.	Antibiotic compositions for the treatment of gram negative infections
CA2767614C (en) *	2009-07-13	2019-01-15	Cempra Pharmaceuticals Inc.	Fusidic acid dosing regimens for treatment of bacterial infections
US8450300B2 (en) *	2009-07-13	2013-05-28	Cempra Pharmaceuticals Inc.	Fusidic acid dosing regimens for treatment of bacterial infections
CA2773033C (en)	2009-09-04	2016-10-11	Mpex Pharmaceuticals, Inc.	Use of aerosolized levofloxacin for treating cystic fibrosis
CN108785654A (zh)	2009-11-23	2018-11-13	丘比斯特制药有限责任公司	脂肽组合物和相关方法
US8247394B2 (en)	2010-06-02	2012-08-21	Cempra Pharmaceuticals Inc.	Methods of treating urethritis and related infections using fusidic acid
US8415307B1 (en)	2010-06-23	2013-04-09	Biosource Pharm, Inc.	Antibiotic compositions for the treatment of gram negative infections
WO2013059610A1 (en)	2011-10-20	2013-04-25	Trius Therapeutics, Inc.	Therapeutic combination of daptomycin and protein synthesis inhibitor antibiotic, and methods of use
US8940897B2 (en)	2012-03-30	2015-01-27	Cubist Pharmaceuticals, Inc.	1,3,4-oxadiazole and 1,3,4-thiadiazole β-lactamase inhibitors
US9655946B2 (en) *	2012-09-11	2017-05-23	Hospira Australia Pty Ltd.	Daptomycin formulations and uses thereof
CN103006562B (zh) *	2013-01-21	2014-09-17	西南大学	达托霉素醇质体制剂
KR102237887B1 (ko)	2013-03-15	2021-04-07	멜린타 서브시디어리 코프.	항생제를 사용하여 과체중 및 비만 환자에서 감염을 치료하는 방법
US10647746B2 (en)	2016-04-08	2020-05-12	Versitech Limited	Antibacterial cyclic lipopeptides
US11667674B2 (en)	2016-04-08	2023-06-06	Versitech Limited	Antibacterial cyclic lipopeptides
EP3454881A1 (de) *	2016-05-13	2019-03-20	Spero Potentiator, Inc.	Potenzierung der antibiotischen wirkung durch ein neuartiges kationisches peptid, spr741
CN114788814B (zh) *	2021-01-26	2023-10-13	浙江创新生物有限公司	一种高稳定性的注射用达托霉素组合物及其制备方法和其应用

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
USRE32455E (en)	1978-10-16	1987-07-07	Eli Lilly And Company	A-21978 antibiotics and process for their production
USRE32333E (en)	1978-10-16	1987-01-20	Eli Lilly And Company	A-21978 Antibiotics and process for their production
USRE32310E (en)	1982-05-21	1986-12-16	Eli Lilly And Company	Derivatives of A-21978C cyclic peptides
US4537717A (en)	1982-05-21	1985-08-27	Eli Lilly And Company	Derivatives of A-21978C cyclic peptides
USRE32311E (en)	1982-05-21	1986-12-16	Eli Lilly And Company	Derivatives of A-21978C cyclic peptides
US4524135A (en)	1982-05-21	1985-06-18	Eli Lilly And Company	A-21978C cyclic peptides
US4482487A (en)	1982-05-21	1984-11-13	Eli Lilly And Company	A-21978C cyclic peptides
US4885243A (en)	1984-10-09	1989-12-05	Eli Lilly And Company	Process for producing A-21978C derivatives
US4800157A (en)	1985-09-09	1989-01-24	Eli Lilly And Company	Process for producing the A-21978C antibiotics
CA1315229C (en)	1987-06-10	1993-03-30	Patrick J. Baker	Chromatographic purification process
US4874843A (en)	1987-12-03	1989-10-17	Eli Lilly And Company	Chromatographic purification process
NZ232763A (en) *	1989-03-06	1991-09-25	Lilly Co Eli	Parenteral formulation comprising daptomycin with a buffer to maintain ph between 6.0 and 8.0
FR2755857B1 (fr) *	1996-11-19	1998-12-24	Rhone Poulenc Rorer Sa	Compositions pharmaceutiques stabilisees, a base de quinupristine et de dalfopristine et leur preparation
FR2772272B1 (fr)	1997-12-16	2000-01-14	Rhone Poulenc Rorer Sa	Compositions pharmaceutiques a base de dalfopristine et de quinupristine et leur preparation
PT1674107T (pt)	1998-09-25	2016-12-07	Cubist Pharmaceuticals Llc	Utilização de daptomicina
US9393093B2 (en)	2008-02-18	2016-07-19	Covidien Lp	Clip for implant deployment device

1999
- 1999-09-24 PT PT60066974T patent/PT1674107T/pt unknown
- 1999-09-24 KR KR1020017003735A patent/KR20010075327A/ko not_active Application Discontinuation
- 1999-09-24 DE DE1999630758 patent/DE122006000049I1/de active Pending
- 1999-09-24 SI SI9931082A patent/SI1674107T1/sl unknown
- 1999-09-24 AT AT99949913T patent/ATE322280T1/de active
- 1999-09-24 EP EP06006697.4A patent/EP1674107B8/de not_active Expired - Lifetime
- 1999-09-24 TR TR2001/00841T patent/TR200100841T2/xx unknown
- 1999-09-24 KR KR1020107006807A patent/KR20100051735A/ko not_active Ceased
- 1999-09-24 ES ES99949913T patent/ES2259845T3/es not_active Expired - Lifetime
- 1999-09-24 DE DE200612000049 patent/DE122006000049I2/de active Active
- 1999-09-24 AU AU62687/99A patent/AU764348B2/en not_active Expired
- 1999-09-24 BR BR9914051-9A patent/BR9914051A/pt not_active Application Discontinuation
- 1999-09-24 DE DE69930758T patent/DE69930758T2/de not_active Expired - Lifetime
- 1999-09-24 EP EP99949913A patent/EP1115417B1/de not_active Revoked
- 1999-09-24 CN CNA200410031708XA patent/CN1530136A/zh active Pending
- 1999-09-24 PT PT99949913T patent/PT1115417E/pt unknown
- 1999-09-24 NZ NZ510690A patent/NZ510690A/xx not_active IP Right Cessation
- 1999-09-24 WO PCT/US1999/022366 patent/WO2000018419A2/en active IP Right Grant
- 1999-09-24 US US09/406,568 patent/US6468967B1/en not_active Expired - Lifetime
- 1999-09-24 PL PL348328A patent/PL203689B1/pl unknown
- 1999-09-24 HU HU0103874A patent/HU230656B1/hu unknown
- 1999-09-24 ES ES06006697.4T patent/ES2603086T3/es not_active Expired - Lifetime
- 1999-09-24 SI SI9930904T patent/SI1115417T1/sl unknown
- 1999-09-24 CA CA002344318A patent/CA2344318C/en not_active Expired - Lifetime
- 1999-09-24 DK DK99949913T patent/DK1115417T3/da active
- 1999-09-24 DK DK06006697.4T patent/DK1674107T3/en active
- 1999-09-24 PL PL384274A patent/PL206091B1/pl unknown
- 1999-09-24 JP JP2000571937A patent/JP4184607B2/ja not_active Expired - Lifetime
- 1999-09-24 CN CNB998124982A patent/CN1150029C/zh not_active Ceased
2001
- 2001-03-14 IS IS5890A patent/IS5890A/is unknown
- 2001-03-22 NO NO20011454A patent/NO20011454L/no not_active Application Discontinuation
2002
- 2002-01-09 HK HK02100152.2A patent/HK1040363B/zh not_active IP Right Cessation
- 2002-02-20 US US10/082,544 patent/US6852689B2/en not_active Expired - Lifetime
2003
- 2003-05-27 JP JP2003149968A patent/JP2003321389A/ja not_active Withdrawn
2004
- 2004-03-04 RU RU2004106569/14A patent/RU2363489C9/ru active
- 2004-08-17 JP JP2004237765A patent/JP2004339238A/ja not_active Withdrawn
2006
- 2006-04-18 CY CY20061100536T patent/CY1105556T1/el unknown
- 2006-06-23 NL NL300232C patent/NL300232I2/nl unknown
- 2006-06-28 LU LU91254C patent/LU91254I2/fr unknown
- 2006-07-18 CY CY200600003C patent/CY2006003I1/el unknown
- 2006-09-22 JP JP2006258107A patent/JP2006335773A/ja not_active Withdrawn
2009
- 2009-03-10 IS IS8807A patent/IS8807A/is unknown
2016
- 2016-11-24 CY CY20161101219T patent/CY1118334T1/el unknown

Also Published As

Publication number	Publication date
JP2002525335A (ja)	2002-08-13
NO20011454L (no)	2001-05-25
DE69930758D1 (de)	2006-05-18
NZ510690A (en)	2002-10-25
SI1115417T1 (sl)	2006-08-31
CA2344318A1 (en)	2000-04-06
NL300232I1 (nl)	2006-09-01
JP4184607B2 (ja)	2008-11-19
DE69930758T2 (de)	2007-04-26
US6852689B2 (en)	2005-02-08
DK1674107T3 (en)	2016-12-19
TR200100841T2 (tr)	2002-01-21
KR20100051735A (ko)	2010-05-17
HK1040363B (zh)	2007-01-26
JP2004339238A (ja)	2004-12-02
CY2006003I2 (el)	2009-11-04
CY2006003I1 (el)	2009-11-04
IS8807A (is)	2009-03-10
NO20011454D0 (no)	2001-03-22
PL206091B1 (pl)	2010-06-30
US6468967B1 (en)	2002-10-22
PT1674107T (pt)	2016-12-07
BR9914051A (pt)	2001-06-19
HU230656B1 (hu)	2017-06-28
AU764348B2 (en)	2003-08-14
EP1115417B1 (de)	2006-04-05
HUP0103874A2 (hu)	2002-02-28
HUP0103874A3 (en)	2002-09-30
RU2004106569A (ru)	2005-08-10
PL203689B1 (pl)	2009-11-30
EP1674107A3 (de)	2012-06-20
CN1530136A (zh)	2004-09-22
WO2000018419A3 (en)	2000-07-06
JP2006335773A (ja)	2006-12-14
PT1115417E (pt)	2006-07-31
CA2344318C (en)	2006-07-04
WO2000018419A2 (en)	2000-04-06
KR20010075327A (ko)	2001-08-09
RU2363489C9 (ru)	2010-03-20
SI1674107T1 (sl)	2017-01-31
DK1115417T3 (da)	2006-07-31
HK1040363A1 (en)	2002-06-07
EP1674107A2 (de)	2006-06-28
US20020142948A1 (en)	2002-10-03
CN1348382A (zh)	2002-05-08
AU6268799A (en)	2000-04-17
EP1674107A8 (de)	2006-10-04
CN1150029C (zh)	2004-05-19
LU91254I2 (fr)	2006-08-28
ES2603086T3 (es)	2017-02-23
IS5890A (is)	2001-03-14
JP2003321389A (ja)	2003-11-11
DE122006000049I1 (de)	2007-01-04
CY1118334T1 (el)	2017-06-28
EP1115417A2 (de)	2001-07-18
EP1674107B8 (de)	2017-01-25
DE122006000049I2 (de)	2007-11-08
RU2363489C2 (ru)	2009-08-10
EP1674107B1 (de)	2016-08-24
PL348328A1 (en)	2002-05-20
ES2259845T3 (es)	2006-10-16
CY1105556T1 (el)	2010-07-28
NL300232I2 (nl)	2007-01-02

Publication	Publication Date	Title
ATE322280T1 (de)	2006-04-15	Verwendung von daptomycin
DK0713701T3 (da)	2000-04-03	2-Brommelatonin til behandling af søvnforstyrrelser
ATE245977T1 (de)	2003-08-15	Therapeutische substituierte guanidine
ATE260658T1 (de)	2004-03-15	Pharmazeutische zubereitungen zur verminderung von atmungsdepressionen
DK0583421T3 (da)	1999-11-22	Substituerede dibenzoxazepinforbindelser, lægemidler og fremgangsmåder til anvendelse
DK1201246T3 (da)	2009-02-23	Anvendelse af trombopoietin som et medikament til behandling og forebyggelse af trombocytopeni
ES2106531T3 (es)	1997-11-01	Compuestos de dibenzoxazepina substituidos en 2, 3, 4, 5, 6, 7, 8, 9 y/o 10, composiciones farmaceuticas y metodos de uso.
IL136733A0 (en)	2001-06-14	Pharmaceutical composition containing sibutramine and orlistat
GB2331926A (en)	1999-06-09	Pharmaceutical compositions containing ibuprofen and domperidone for the treatment of migraine
HUP0000110A2 (hu)	2000-06-28	Azaciklusos, azabiciklusos vagy tetrahidropiridinszármazékokat tartalmazó, fájdalom kezelésére alkalmas gyógyászati készítmények
DE69626050D1 (de)	2003-03-06	Pharmazeutische zusammensetzung enthaltend interferon-gamma stimulatoren
SE9803623D0 (sv)	1998-10-22	New therapeutic application